SEE Invest SA
SEE Invest reported total assets of €1.20m at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Aug 2026).
The score of SEE Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -14 % Total assets +19 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
SEE Invest's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Aug 2026
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 20 Aug 2024
- Year ended 31 Dec 2022filed on 29 Sep 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
SEE Invest's financial analysis
- Solvency29.2%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of SEE Invest
SEE Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0451.463.635
- VAT number
- BE0451463635
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 20 Dec 1993
- Registered office
- 9681 Maarkedal
- Latest accounts
- 2025 · filed on 06 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
SEE Invest (SA) has been based in Maarkedal since 1993, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 88,545 € and equity of 348,748 €; its revenue is not published. Its solvency stands at 29.2%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to SEE Invest
Companies in the same business, of comparable size and area, outside its group.
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- AUXI Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €1.20m
- Laerdal Benelux Wholesale of pharmaceutical and medical goods Vilvoorde · balance sheet €1.21m
Frequently asked questions about SEE Invest
What is the revenue of SEE Invest?
SEE Invest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of SEE Invest?
In Belgium, the VAT number is the company number prefixed with BE: BE0451463635 for SEE Invest, if the company is VAT-registered. Its company number (CBE) is 0451.463.635.
Where is the registered office of SEE Invest?
According to the CBE register, the registered office of SEE Invest is in 9681 Maarkedal.
What is the equity of SEE Invest?
At the close of the 2025 financial year, the equity of SEE Invest amounts to 348,748 €, a solvency of 29.2% of total assets.
Who manages SEE Invest?
The register lists 2 active mandates at SEE Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of SEE Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →